✦ LIBER ✦

Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease

✍ Scribed by G.B. John Mancini; Mahyar Etminan; Bin Zhang; Linda E. Levesque; J. Mark FitzGerald; James M. Brophy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Beta Blockers, Angiotensin-Con

✍ Hoang M. Lai; Wilbert S. Aronow; Adam Kruger; Harit Desai; Harshad Amin; William 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Angiotensin-converting enzyme inhibitors

✍ Alan K. Berger; Sue Duval; Connie Manske; Gabriela Vazquez; Cheryl Barber; Lesli 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Prescriptions for angiotensin-converting

✍ Pei-Tzu Wang; Yaw-Bin Huang; Ming-Yen Lin; Pei-Fen Chuang; Shang-Jyh Hwang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 467 KB

Effect of Angiotensin-Converting Enzyme

✍ Ahmed M. Selim; Israa Soghier; Pradnya Velankar; Ronald Zolty 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 153 KB

The Impact of angiotensin-converting enz

✍ Shilpa M. Patel; Evan Stashefsky; Marie-Claire Maroun; Leonard B. Johnson 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Complementary effects of angiotensin-con

✍ Elizabeth Ripley 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 159 KB